Nasdaq-listed medical device technology firm BioSig Technologies and real-world asset tokenization company Streamex are looking to raise up to $1.1 billion in financing to launch a gold-backed treasury management strategy powered by Solana.
BioSig and Streamex said in a press release on July 8 that the companies have entered into a definitive agreement that will see them raise up to $1.1 billion from a leading institutional investor.
Streamex & BioSig plan to raise the funds via a debenture, offering the sale of $100 million in senior secured convertible notes and equity line of credit of up to $1 billion. The debentures will be convertible into shares of BioSig’s common stock.
Per the announcement, BioSig and Streamex are eyeing a real-world assets footprint via gold. Their goal is to bring a chunk of the $142 trillion commodities market onchain via Solana (SOL).
Blockchain technology will help unlock liquidity, transparency and accessibility, said BioSig chief executive officer and Streamex co-founder Henry McPhie.
“This financing marks a pivotal moment not only for Streamex and BioSig, but for the evolution of global financial markets. By combining the value of physical gold with the innovation of blockchain, we are building a company grounded in what we believe to be the world’s most trusted store of value while enabling a scalable, high-return business model through tokenization,” McPhie added.
Gold tokenization a huge opportunity
BioSig’s announcement follows a merger with Streamex that saw the company become one of Nasdaq’s largest gold bullion holders, and the financing initiative, led by Cantor Fitzgerald, Clear Street and Needham & Company as placement agents seeks to cement this status. CIBC World Markets acted as strategic advisor.
Streamex sees
Go to Source to See Full Article
Author: Benson Toti